Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

28.84

-0.26 (-0.89%)

At close: Oct 16, 2026, 4:00 PM EDT

28.37

-0.47 (-1.64%)

After-hours: Oct 16, 2026, 7:58 PM EDT

Arcutis Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,622	3,557	1,630	305	901	1,043
Market Cap Growth	39.67%	118.17%	434.82%	-66.18%	-13.58%	-14.88%
Enterprise Value	3,498	3,480	1,508	283	626	681
Last Close Price	28.82	29.04	13.93	3.23	14.80	20.74

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	42.28	76.62	-	-	-	-
PS Ratio	7.81	9.46	8.30	5.11	244.56	-
PB Ratio	16.41	18.77	10.35	3.44	4.30	3.50
P/TBV Ratio	17.51	20.36	11.01	3.71	4.45	3.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	7.54	9.25	7.67	4.75	169.88	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.52	0.60	0.70	2.32	0.97	0.26
Net Debt / Equity Ratio	-0.56	-0.56	-0.75	-0.74	-0.99	-1.04
Net Debt / EBITDA Ratio	-3.41	14.08	0.94	0.27	0.69	1.50
Net Debt / FCF Ratio	-3.18	16.87	1.05	0.27	0.80	1.76
Asset Turnover	1.10	0.96	0.57	0.15	0.01	-
Inventory Turnover	1.49	1.98	1.38	0.48	-	-
Quick Ratio	2.46	2.83	3.72	6.38	11.06	11.61
Current Ratio	2.92	3.17	4.14	7.08	11.57	12.09
Return on Equity (ROE)	15.86%	-9.30%	-113.76%	-175.79%	-122.80%	-72.62%
Return on Assets (ROA)	5.09%	-1.96%	-23.25%	-38.12%	-43.97%	-36.55%
Return on Capital Employed (ROCE)	10.40%	-4.00%	-47.90%	-81.80%	-73.30%	-55.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.79%	-0.45%	-8.59%	-85.99%	-34.55%	-19.78%
FCF Yield	1.08%	-0.18%	-6.89%	-81.18%	-28.63%	-16.84%
Buyback Yield / Dilution	-5.07%	-5.19%	-74.53%	-25.94%	-11.39%	-38.52%

SEC Filings: 10-K · 10-Q